With reference to letter bearing reference no. L/SURV/ONL/PV/AV/2024-2025/2678 dated 23rd September 2024 seeking clarification on price movement, Concord Biotech has informed that the company is in compliance with Regulation 30 of SEBI (LODR) Regulations 2015, and has been promptly informing the stock exchanges on all events and information, which have a bearing on operation or performance of the company. There is no undisclosed / price sensitive information or any impending announcement / corporate action which needs to be informed to the exchange at this point of time. Further assured that the Company will, as required Regulation 30 of the SEBI (LODR) Regulations 2015, continue to promptly inform the exchanges of all material events / information / actions.
The above information is a part of company’s filings submitted to BSE.
